Use the Search Fields to Find Information
Page 69 of 348
Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
Please use this link to access this publication. Abstract This study was designed to test our hypothesis that an ultra-low dose of delta-9 tetrahydrocannabinol (THC) reverses age-dependent cognitive
September 4, 2024
Resting state functional connectivity in the default mode network: Relationships between cannabis use, gender, and cognition in adolescents and young adults
Abstract Introduction Cannabis is the most commonly used illicit substance in the United States, and nearly 1 in 4 young adults are current cannabis users.
August 2, 2025
Residual Effects of Cannabis Use on Effort-Based Decision-Making
Please use this link to access this publication. Abstract Objective:Acute Δ9-tetrahydrocannabinol (THC) administration in humans (Lawn etal., 2016) and rats (Silveira, Adams, Morena, Hill, & Winstanley, 2016)
August 21, 2025
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Abstract Background: Emerging evidence supports cannabidiol (CBD) as a promising therapeutic compound for various health conditions, despite its approval as a medication (product for medical
December 21, 2025
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments. This
September 19, 2019
Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease
Abstract Neuropathic pain is one of the most invalidating symptoms in patients with Fabry disease (FD), affecting their quality of life, it is linked to small fiber
December 7, 2023
Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year
Abstract Introduction: Subjective improvement in gastrointestinal (GI) symptoms was assessed among patients using medical marijuana (MMJ). Methods: Participants completed surveys at 0 days, 30 days, 6 months, and
March 6, 2025
Release of delta-9-tetrahydrocannabinol from polyvinyl alcohol hydrogels and its safe interaction with human skin fibroblasts
Abstract This study aimed to design a THC-rich hydrogel to deliver cannabis derivatives topically. We developed hydrogels using polyvinyl alcohol (PVA) mixed with propylene glycol
September 5, 2024
Relationships between eicosanoids and cannabinoids: Are eicosanoids cannabimimetic agents?
September 19, 2019
Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder
Abstract Background From a secondary prevention perspective, it is useful to know who is at greatest risk of progressing from substance initiation to riskier patterns
August 23, 2025
Page 69 of 348